Press "Enter" to skip to content

December Vaccine Rollout Possible, BioNTech CEO Says

Shares

Key Points

  • BioNTech co-founder Ugur Sahin said on Thursday the frontrunner COVID-19 vaccine his German firm is developing with Pfizer could be rolled out before the year is over in the United States or Europe.
  • The BioNTech/Pfizer shot and another one being developed by US firm Moderna have taken the lead in the global chase for a vaccine, after large-scale trial data this month showed that their jabs were around 95 percent effective against COVID-19.
  • The US, the European Union and a slew of other nations have already placed orders for hundreds of millions of doses of the top vaccine candidates in development.
  • Visit The Financial Today’s homepage for more stories.

FRANKFURT AM MAIN — BioNTech co-founder Ugur Sahin said on Thursday the frontrunner COVID-19 vaccine his German firm is developing with Pfizer could be rolled out before the year is over in the United States or Europe.

“We are working at full speed,” he told AFP in a Zoom interview, confirming that the companies planned to apply for emergency use authorization of their jab in the US on Friday, while European regulators will receive another batch of data “next week.”

“There is a chance that we can receive approval from the US or Europe or both regions this year still,” said Sahin, 55, who is also BioNTech’s chief executive.

Get unlimited access to TFT Premium content for FREE!

Join 23,000+ subscribers and enjoy free access to TFT premium news & stories!

Be First to Comment

Leave a Reply